DE60024669T2 - Hämatologische bestimmung und reagenz - Google Patents

Hämatologische bestimmung und reagenz Download PDF

Info

Publication number
DE60024669T2
DE60024669T2 DE60024669T DE60024669T DE60024669T2 DE 60024669 T2 DE60024669 T2 DE 60024669T2 DE 60024669 T DE60024669 T DE 60024669T DE 60024669 T DE60024669 T DE 60024669T DE 60024669 T2 DE60024669 T2 DE 60024669T2
Authority
DE
Germany
Prior art keywords
factor
coagulation
sample
test according
reagent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60024669T
Other languages
German (de)
English (en)
Other versions
DE60024669D1 (de
Inventor
Maria Patrizia GEMPELER
Andreas Calatzis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DSM IP Assets BV
Original Assignee
Pentapharm AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pentapharm AG filed Critical Pentapharm AG
Application granted granted Critical
Publication of DE60024669D1 publication Critical patent/DE60024669D1/de
Publication of DE60024669T2 publication Critical patent/DE60024669T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/4609—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates from reptiles
    • G01N2333/4613—Snake venom
    • G01N2333/4616—Snake venom from Russell's viper
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/7456—Factor V
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96444—Factor X (3.4.21.6)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60024669T 1999-12-15 2000-12-14 Hämatologische bestimmung und reagenz Expired - Lifetime DE60024669T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
WOPCT/EP99/09952 1999-12-15
PCT/EP1999/009952 WO2001044493A2 (en) 1999-12-15 1999-12-15 Hematological assay and reagent
PCT/EP2000/012753 WO2001044819A2 (en) 1999-12-15 2000-12-14 Hematological assay and reagent

Publications (2)

Publication Number Publication Date
DE60024669D1 DE60024669D1 (de) 2006-01-12
DE60024669T2 true DE60024669T2 (de) 2006-09-28

Family

ID=8167528

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60024669T Expired - Lifetime DE60024669T2 (de) 1999-12-15 2000-12-14 Hämatologische bestimmung und reagenz

Country Status (9)

Country Link
US (1) US6994984B2 (https=)
EP (1) EP1240528B1 (https=)
JP (1) JP4762472B2 (https=)
AT (1) ATE312352T1 (https=)
AU (2) AU2431800A (https=)
CA (1) CA2392350C (https=)
DE (1) DE60024669T2 (https=)
ES (1) ES2254260T3 (https=)
WO (2) WO2001044493A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1918718A1 (de) * 2006-10-31 2008-05-07 Roche Diagnostics GmbH Verfahren und Vorrichtungen zur elektrochemischen Bestimmung von Faktor Xa-Inhibitoren in Blutproben

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6680177B2 (en) * 2001-12-07 2004-01-20 Cardiovascular Diagnostics, Inc. Low molecular weight heparin assay, system and reagent therefor
US7358337B2 (en) * 2002-08-16 2008-04-15 International Technidyne Corporation Assay for low molecular weight heparin
US7727736B2 (en) 2003-09-22 2010-06-01 The University Of North Carolina At Chapel Hill Soluble phospholipids for use in clotting factor assays
EP1745145A4 (en) 2004-05-11 2008-03-26 Heptest Lab Inc COMPOSITIONS, KIT AND METHOD IN ONE STEP FOR MONITORING COMPOUNDS HAVING XA AND / OR ANTIFACTOR IIA ANTIFACTOR ACTIVITIES
GB2433592A (en) * 2005-12-23 2007-06-27 Pentapharm Ag Assay for thrombin inhibitors
EP2333555A1 (de) 2009-12-09 2011-06-15 Siemens Healthcare Diagnostics Products GmbH Heterogener Gerinnungstest
JP2011133396A (ja) * 2009-12-25 2011-07-07 Sysmex Corp 活性化部分トロンボプラスチン時間測定試薬、活性化部分トロンボプラスチン時間測定方法、及び血液凝固抑制物質の有無の判定方法
EP2484775A1 (de) * 2011-02-07 2012-08-08 Siemens Healthcare Diagnostics Products GmbH Heparin-insensitives Verfahren zur Bestimmung von direkten Gerinnungsfaktorinhibitoren
RU2517116C2 (ru) * 2012-07-03 2014-05-27 Государственное бюджетное учреждение Санкт-Петербургский научно-исследовательский институт скорой помощи им. И.И. Джанелидзе Способ оценки состояния свертывающей системы крови у пациентов, находящихся в критическом состоянии
US10001495B2 (en) 2012-07-25 2018-06-19 Bioverativ Therapeutics Inc. Blood factor monitoring assay and uses thereof
WO2014183886A1 (en) 2013-05-14 2014-11-20 Struszym, S.L. Test strips for determining coagulation factor activities
ES2903154T3 (es) 2013-12-09 2022-03-31 Dsm Ip Assets Bv Identificación de anticoagulantes en una muestra
CN107106662B (zh) * 2014-10-23 2022-03-25 Q-塞拉有限公司 改善的凝血组合物
JP6873833B2 (ja) * 2017-06-09 2021-05-19 シスメックス株式会社 血液検体の判定方法、血液検体分析装置及びコンピュータプログラム
JP7110360B2 (ja) 2017-10-09 2022-08-01 テルモ ビーシーティー バイオテクノロジーズ，エルエルシー 凍結乾燥方法
CN108982865B (zh) * 2018-08-16 2021-05-11 上海原科实业发展有限公司 一种血栓弹力图法肝素定量检测试剂盒及其制备方法
CN109082458B (zh) * 2018-08-16 2024-02-23 上海原科实业发展有限公司 一种血栓弹力图法定量检测口服凝血因子Xa抑制剂试剂盒及其制备方法
CN109709344A (zh) * 2018-12-29 2019-05-03 贵州金玖生物技术有限公司 一种活化凝血检测试剂、其制备方法及其应用
CN113614477B (zh) 2019-03-14 2023-04-28 泰尔茂比司特生物技术有限公司 冷冻干燥装载托盘组件及系统
CN110244066A (zh) * 2019-07-01 2019-09-17 北京乐普医疗科技有限责任公司 一种干式电化学法凝血酶原时间检测卡及制备方法
CN110887970B (zh) * 2019-11-29 2023-10-31 北京赛科希德科技股份有限公司 抽提缓冲液、兔脑抽提液、pt检测试剂及pt检测试剂盒
MX2022013141A (es) * 2020-04-24 2023-01-19 Perosphere Tech Inc Sistemas de muestras de control de sangre total y metodo de preparacion y uso de las mismas.
US20240044921A1 (en) * 2020-12-28 2024-02-08 Fujimori Kogyo Co., Ltd. Method for evaluating blood coagulation performance, and method for inspecting risk of thrombosis
JPWO2022145477A1 (https=) * 2020-12-28 2022-07-07
CN117098996A (zh) 2021-03-31 2023-11-21 美国血液技术公司 止血测量装置质量控制制剂
CN114703252B (zh) * 2022-06-02 2022-11-04 深圳市帝迈生物技术有限公司 一种用于检测血浆中水蛭素、比伐卢定、达比加群含量的试剂盒
EP4658806A1 (en) * 2023-02-01 2025-12-10 Haemonetics Corporation Disposable cartridge for classification of anticoagulant and method of use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3516579A1 (de) * 1984-11-19 1986-05-22 Boehringer Mannheim Gmbh, 6800 Mannheim Gerinnungstest auf teststreifen
US5164598A (en) 1985-08-05 1992-11-17 Biotrack Capillary flow device
US4756884A (en) 1985-08-05 1988-07-12 Biotrack, Inc. Capillary flow device
US4946775A (en) * 1985-09-05 1990-08-07 Yin E Thye Composition, kit and method for assaying heparin and a method for making the composition
DE3616496A1 (de) 1986-05-16 1987-11-19 Boehringer Mannheim Gmbh Analyseelement zur bestimmung von gerinnungsparametern
US5110727A (en) 1987-04-03 1992-05-05 Cardiovascular Diagnostics, Inc. Method for performing coagulation assays accurately, rapidly and simply, using dry chemical reagents and paramagnetic particles
US5266462A (en) * 1992-06-03 1993-11-30 Baxter Diagnostics Inc. Measurement of platelet activities
AU8388098A (en) * 1997-07-11 1999-02-08 Mount Sinai School Of Medicine Of The City University Of New York, The Assays for diagnosis of thrombophilic disease

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1918718A1 (de) * 2006-10-31 2008-05-07 Roche Diagnostics GmbH Verfahren und Vorrichtungen zur elektrochemischen Bestimmung von Faktor Xa-Inhibitoren in Blutproben
WO2008052718A1 (de) * 2006-10-31 2008-05-08 Roche Diagnostics Gmbh Verfahren und vorrichtungen zur elektrochemischen bestimmung von faktor xa-inhibitoren in blutproben

Also Published As

Publication number Publication date
CA2392350A1 (en) 2001-06-21
JP4762472B2 (ja) 2011-08-31
WO2001044493A2 (en) 2001-06-21
JP2003517610A (ja) 2003-05-27
AU3159301A (en) 2001-06-25
EP1240528B1 (en) 2005-12-07
EP1240528A2 (en) 2002-09-18
ATE312352T1 (de) 2005-12-15
WO2001044819A3 (en) 2001-12-06
ES2254260T3 (es) 2006-06-16
DE60024669D1 (de) 2006-01-12
CA2392350C (en) 2010-11-02
AU776845B2 (en) 2004-09-23
US6994984B2 (en) 2006-02-07
US20030104508A1 (en) 2003-06-05
AU2431800A (en) 2001-06-25
WO2001044819A2 (en) 2001-06-21

Similar Documents

Publication Publication Date Title
DE60024669T2 (de) Hämatologische bestimmung und reagenz
DE69018910T2 (de) Verfahren zur Bestimmung des endogenen Thrombinpotentials von Plasma und Blut und Reagenziensatz zur Verwendung in besagtem Verfahren.
DE69108896T2 (de) Verfahren zur bestimmung der konzentration von antikoagulantien.
EP0915340B1 (de) Verfahren zur Bestimmung des antikoagulatorischen Potentials einer Probe und Verfahren zur Bestimmung der Glykosilierung von Thrombomodulin
DE60011274T2 (de) Verfahren, reagenz und messkartusche zur bestimmung der gerinnungszeit
EP0236985B1 (de) Verfahren zur photometrischen Bestimmung der Protein C- und/oder Protein S-Aktivität
EP0711838B2 (de) Verfahren zum spezifischen Nachweis eines aktivierten Gerinnungsfaktors V mit einer erhöhten Stabilität gegenüber aktiviertem Protein C
EP0696642B1 (de) Verfahren zum Nachweis von Störungen des Protein C/Protein S-Systems
EP0972203B1 (de) REAGENS ZUR BESTIMMUNG DER aPTT
DE69016858T2 (de) Verfahren und Reagenziensatz zur Bestimmung der funktionalen Aktivität von Protein S in menschlichem Plasma.
DE112006003476T5 (de) Verfahren und Systeme zum Nachweisen und Quantifizieren indirekter Thrombininhibitoren
EP0975975A1 (de) Verfahren zur bestimmung von aktivierten blutgerinnungsfaktoren in plasma und plasmaderivaten
EP0977995B1 (de) Verfahren zum funktionellen nachweis von störungen im protein c-system
JPH07270406A (ja) 合成燐脂質試薬
EP0445626B1 (de) Funktioneller Test zur Bestimmung der Protein S-Aktivität
EP0408075B1 (de) Verfahren und Reagenz zur Bestimmung von Antithrombin III
EP0570355B1 (de) Verwendung von Prothrombinfragmenten
EP4239338A1 (de) Globaltest zur feststellung des status des blutgerinnungssystems
EP2316931B1 (de) Polymergekoppelte Peptidasen
DE19714559C1 (de) Verfahren zur Bestimmung von aktivierten Blutgerinnungsfaktoren in Plasma und Plasmaderivaten
Berthier et al. A multicenter study on amidolytic factor X evaluation in oral anticoagulant therapy
DE19506263A1 (de) Verfahren zum spezifischen Nachweis eines Gerinnungsfaktors V mit einer erhöhten Stabilität gegenüber aktiviertem Protein C im aktivierten Zustand
DD243995A1 (de) Verfahren zur bestimmung der aktivierten gerinnungsfaktor-x-assoziierten aktivitaet

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: DSM IP ASSETS B.V., HEERLEN, NL